CC BY-NC-ND 4.0 · Journal of Social Health and Diabetes 2013; 01(02): 090-093
DOI: 10.4103/2321-0656.115307
Original Article
NovoNordisk Education Foundation

Process evaluation of glucometer based diabetes screening initiative in India: Early experiences from North India

Deepak Sharma
Department of Community Medicine, School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India
,
Khumukcham Trusty
Department of Community Medicine, School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India
,
Amarjeet Singh
Department of Community Medicine, School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India
› Author Affiliations
Further Information

Publication History

Publication Date:
19 November 2018 (online)

Abstract

Background: Government of India, launched population based screening for diabetes under the National Program for Prevention and Control of Cancer, Diabetes, Cardio-vascular Diseases and Stroke (NPCDCS). There is a need to get early feedback and to fine tune this program.

Aims and Objectives: (1) To assess the current status of the implementation of NPCDCS piloted at sub-center level in one district of Haryana. (2) To assess the views of health workers and community leaders regarding this newly launched program.

Materials and Methods: This qualitative study was carried in selected villages of Ambala district in North India from July 2012 to December 2012. The study used in-depth interview with screened persons and health-care workers of the study area. Field notes were taken. Informal conversations with community leaders were held.

Results: Residents were not made aware of screening activity prior to and after launching of the health program. There was anxiety among residents regarding screening. There was no focus on health promotion activities. There was a shortage of self-diagnostic kits for screening diabetes.

Conclusion: Adequate priming of the population was not carried out before launching the NPCDCS program. Validation of kit is questionable. Continuity of medical care in patients screened for diabetes was missing.